GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment


Marc Hertz, PhD, CEO of GRI Bio underscores importance of the interim data from their ongoing Phase 2a biomarker study for Idiopathic Pulmonary Fibrosis (IPF)

Read more from the original source:
GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment

Related Posts